SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FDC - Quaterly Results

14 Nov 2022 Evaluate
The Revenue for the quarter ended  September 2022 of Rs. 4462.21 millions grew by 12.60 % from Rs. 3962.85 millions.Net profit of the cmpany stood at Rs. 512.76 millions for the quarter ended September 2022 a decline of -30.29% from Rs. 735.51 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 797.60 millions from 1027.19 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 4462.21 3962.85 12.60 9392.29 8412.47 11.65 15189.65 13254.49 14.60
Other Income 286.31 305.76 -6.36 480.30 540.10 -11.07 787.34 971.46 -18.95
PBIDT 797.60 1027.19 -22.35 1791.78 2401.95 -25.40 3255.80 4214.76 -22.75
Interest 10.11 7.17 41.00 17.07 15.17 12.52 30.48 34.02 -10.41
PBDT 787.49 1020.02 -22.80 1774.71 2386.78 -25.64 3225.32 4180.74 -22.85
Depreciation 99.38 94.36 5.32 192.55 189.31 1.71 370.81 376.23 -1.44
PBT 688.11 925.66 -25.66 1582.16 2197.47 -28.00 2854.51 3804.51 -24.97
TAX 175.35 190.15 -7.78 339.21 460.87 -26.40 658.15 859.61 -23.44
Deferred Tax -7.65 0.15 -5200.00 -86.79 -40.13 116.27 -21.85 14.45 -251.21
PAT 512.76 735.51 -30.29 1242.95 1736.60 -28.43 2196.36 2944.90 -25.42
Equity 165.91 168.81 -1.72 165.91 168.81 -1.72 168.81 168.81 0.00
PBIDTM(%) 17.87 25.92 -31.04 19.08 28.55 -33.19 21.43 31.80 -32.59

FDC Share Price

358.65 2.60 (0.73%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×